by TractManager | Aug 28, 2019 | Emerging Technology Report
The Barostim neo System is an implantable neuromodulation device designed to improve cardiac function by delivering electrical stimulation to baroreceptors in the wall of the carotid artery. The system is designed to take advantage of the body’s natural baroreflex...
by TractManager | Aug 28, 2019 | Emerging Technology Report
The Barostim neo System is an implantable neuromodulation device designed to improve cardiac function by delivering electrical stimulation to baroreceptors in the wall of the carotid artery. The system is designed to take advantage of the body’s natural baroreflex...
by TractManager | Aug 26, 2019 | Molecular Test Assessment
This report evaluates the analytical validity, clinical validity, and clinical utility of the CANCERPLEX test. According to the laboratory, the test is intended to identify patients who are most likely to respond to immune checkpoint inhibition and detect the presence...
by TractManager | Aug 26, 2019 | Health Technology Assessment
Health Problem: Ovarian cancer (OC) is the leading cause of death from gynecologic cancer in the United States and the fifth most common type of cancer-related death among women. In 2015, the 5-year survival rate for women diagnosed with OC was 47.6%. A woman’s...
by TractManager | Aug 22, 2019 | Health Technology Assessment
Health Problem: Uterine fibroids (UFs) (also called leiomyomata or myomas) are benign tumors of the myometrium, the smooth muscle layer of the uterus. Approximately 25% of fibroids are symptomatic. Fibroids are the most common indication for hysterectomy in many...
Recent Comments